Pasar al contenido principal

CAMBIOS DINAMICOS EN LA RESPUESTA INMUNITARIA ESPECIFICA DE VHC DURANTE Y DESPUES DEL TRATAMIENTO CON DAAS PARA DESENTRAÑAR NUEVOS ENFOQUES PARA EL DESARROLLO DE VACUNAS PROFILÁCTICAS.

PI19/00533

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Centro realización INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO VALLE DE HEBRON (VHIR)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Deep Sequencing Reveals Dual Evolution of SARS-CoV-2, Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants

  • Campos, Carolina|||0000-0002-0132-7027
  • Ibañez Lligoña, Marta|||0000-0003-3428-2168
  • Colomer Castell, Sergi|||0000-0002-0307-7455
  • Gregori i Font, Josep|||0000-0002-4253-8015
  • Garcia-Cehic, D.|||0000-0002-0009-038X
  • Andrés, Cristina|||0000-0002-3200-0895
  • Piñana, Maria|||0000-0002-4766-2613
  • González Sánchez, Alejandra|||0000-0002-1809-3415
  • Rando-Segura, Ariadna|||0000-0003-4555-7286
  • Esperalba, Juliana|||0000-0003-1326-1341
  • Saubi, Narcis|||0000-0001-5493-1044
  • Cortese, Maria Francesca|||0000-0002-4318-532X
  • Tabernero, David|||0000-0002-1146-4084
  • Rodríguez Frías, Francisco|||0000-0002-9128-7013
  • Ferrer Costa, Roser|||0000-0002-8925-3172
  • Esteban Mur, Juan Ignacio|||0000-0001-5085-917X
  • Kakze-van der Honing, Renate W.
  • Kampfraath, Andries A.
  • Vergara-Alert, Júlia|||0000-0001-7484-444X
  • Segalés Coma, Joaquim|||0000-0002-1539-7261
  • van der Poel, Wim H. M.
  • Pumarola Suñé, Tomàs|||0000-0002-5171-7461
  • Antón Pagarolas, Andrés, 1976-|||0000-0002-1476-0815
  • Quer, Josep|||0000-0003-0014-084X
SARS-CoV-2 has evolved from early variants dominating the first (B.1.5, B.1.1) and second (B.1.177) pandemic waves, which exhibited a higher frequency of minority mutants with deletions leading to Defective Viral Genomes (DVGs) in the spike region near the S1/S2 cleavage site than the Alpha, Beta, and Delta variants. The emergence of Omicron has significantly altered the dominant variant profile, with Omicron subvariants now representing 100% of circulating viruses. To monitor the evolution and adaptation of Omicron in the human population, a deep-sequencing study was performed in RNA samples of BA.1, BA.1.1, BA.2, BA.5, BQ.1.1, XBB.1.5 and BA.2.86 Omicron subvariants. The findings reveal two occurrences of similar evolutionary patterns within SARS-CoV-2 characterized by a shift from a significant to a very low production of DVGs. This event suggests that DVGs might play a role in the virus's spread and adaptation for persistence in infected humans.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing

  • Llorens-Revull, Meritxell|||0000-0002-8671-8907
  • Martínez-González, Brenda|||0000-0002-4482-5181
  • Quer, Josep|||0000-0003-0014-084X
  • Esteban Mur, Juan Ignacio|||0000-0001-5085-917X
  • Núñez-Moreno, Gonzalo|||0000-0001-5982-570X
  • Minguez, Pablo|||0000-0003-4099-9421
  • Burgui, Idoia
  • Ramos-Ruiz, Ricardo|||0000-0002-6331-9786
  • Soria Benito, María Eugenia|||0000-0002-4719-3351
  • Rico, Angie
  • Riveiro Barciela, Mar|||0000-0001-9309-2052
  • Sauleda, Silvia|||0000-0001-7343-9557
  • Piron, Maria|||0000-0001-6858-9374
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
  • Rodríguez Frías, Francisco|||0000-0002-9128-7013
  • Rando-Segura, Ariadna|||0000-0003-4555-7286
  • Ramírez Serra, Clara|||0000-0001-8971-1711
  • Camós Anguila, Sílvia|||0000-0002-0478-8494
  • Domingo, Esteban
  • Bes, Marta|||0000-0001-6103-072X
  • Perales Viejo, Celia|||0000-0003-1618-1937
  • Costafreda Salvany, Maria Isabel|||0000-0002-3114-3034
MicroRNAs (miRNAs) encapsulated in extracellular vesicles (EVs) are potential diagnostic and prognostic biomarkers. However, discrepancies in miRNA patterns and their validation are still frequent due to differences in sample origin, EV isolation, and miRNA sequencing methods. The aim of the present study is to find a reliable EV isolation method for miRNA sequencing, adequate for clinical application. To this aim, two comparative studies were performed in parallel with the same human plasma sample: (i) isolation and characterization of EVs obtained using three procedures: size exclusion chromatography (SEC), iodixanol gradient (GRAD), and its combination (SEC+GRAD) and (ii) evaluation of the yield of miRNA sequences obtained using NextSeq 500 (Illumina) and three miRNA library preparation protocols: NEBNext, NEXTFlex, and SMARTer smRNA-seq. The conclusion of comparison (i) is that recovery of the largest amount of EVs and reproducibility were attained with SEC, but GRAD and SEC+GRAD yielded purer EV preparations. The conclusion of (ii) is that the NEBNext library showed the highest reproducibility in the number of miRNAs recovered and the highest diversity of miRNAs. These results render the combination of GRAD EV isolation and NEBNext library preparation for miRNA retrieval as adequate for clinical applications using plasma samples.
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Deep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants

  • Campos, Carolina
  • Ibañez-Lligoña, Marta
  • Colomer‑Castell, Sergi
  • Gregori, Josep
  • Garcia‑Cehic, Damir
  • Andrés, Cristina
  • Piñana, Maria
  • González‑Sánchez, Alejandra
  • Rando‑Segura, Ariadna
  • Esperalba, Juliana
  • Saubí, Narcis
  • Cortese, Maria Francesca
  • Tabernero, David
  • Rodriguez-Frias, Francisco
  • Ferrer, Roser
  • Esteban, Juan Ignacio
  • Kakze-van der Honing, Renate W.
  • Kampfraath, Andries A.
  • Vergara-Alert, Júlia
  • Segalés, Joaquim
  • van der Poel, Wim H. M.
  • Pumarola, Tomàs
  • Antón, Andrés
  • Quer, Josep
SARS‐CoV‐2 has evolved from early variants dominating the first (B.1.5, B.1.1) and second (B.1.177) pandemic waves, which exhibited a higher frequency of minority mutants with deletions leading to Defective Viral Genomes (DVGs) in the spike region near the S1/S2 cleavage site than the Alpha, Beta, and Delta variants. The emergence of Omicron has significantly altered the dominant variant profile, with Omicron subvariants now representing 100% of circulating viruses. To monitor the evolution and adaptation of Omicron in the human population, a deep‐sequencing study was performed in RNA samples of BA.1, BA.1.1, BA.2, BA.5, BQ.1.1, XBB.1.5 and BA.2.86 Omicron subvariants. The findings reveal two occurrences of similar evolutionary patterns within SARS‐CoV‐2 characterized by a shift from a significant to a very low production of DVGs. This event suggests that DVGs might play a role in the virus's spread and adaptation for persistence in infected humans., This study was supported by Spanish Ministry of Education, Centro para el Desarrollo Tecnológico Industrial (CDTI), Fondo de Investigación Sanitaria, Spanish Ministry of Economy and Competitiveness, Fundació Institut de Recerca Hospital Universitari Vall d'Hebron, 'la Caixa' Foundation, Consorcio Centro de Investigación Biomédica en Red (CIBER), and Early Response and Rapid Action Zoonotic Emergencies Program (ERRAZE)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients

  • Llorens Revull, Meritxell
  • Dopazo Taboada, Cristina
  • Rodríguez Frias, Francisco
  • Garcia Cehic, Damir
  • Soria Benito, Maria Eugenia
  • Chen, Qian
  • Perales Viejo, Celia Belen
  • Quer Sivila, Josep
  • Bilbao Aguirre, Itxarone Izaskun
  • Rando Segura, Ariadna
  • Gregori Font, Josep
  • Esteban Mur, Juan Ignacio
Fibrosis; Hepatitis C virus; Viral load, Fibrosis; Virus de la hepatitis C; Carga viral, Fibrosi; Virus de l'hepatitis C; Càrrega viral, Cirrhosis derived from chronic hepatitis C virus (HCV) infection is still a common indication for liver transplantation (LT). Reinfection of the engrafted liver is universal in patients with detectable viral RNA at the time of transplant and causes fast progression of cirrhosis (within 5 years) in around one-third of these patients. To prevent damage to the liver graft, effective direct-acting antiviral (DAA) therapy is required as soon as possible. However, because of post-LT clinical instability, it is difficult to determine the optimal time to start DAAs with a low risk of complications. Evaluate changes in quasispecies complexity following LT and seek a predictive index of fast liver damage progression to determine the timing of DAA initiation. HCV genomes isolated from pre-LT and 15-day post-LT serum samples of ten patients, who underwent orthotopic LT, were quantified and sequenced using a next-generation sequencing platform. Sequence alignments, phylogenetic trees, quasispecies complexity measures, biostatistics analyses, adjusted R2 values, and analysis of variance (ANOVA) were carried out. Three different patterns of reinfection were observed (viral bottlenecking, conserved pre-LT population, and mixed populations), suggesting that bottlenecking or homogenization of the viral population is not a generalized effect after liver graft reinfection. None of the quasispecies complexity measures predicted the future degree of liver damage. Higher and more uniform viral load (VL) values were observed in all pre-LT samples, but values were more dispersed in post-LT samples. However, VL increased significantly from the pre-LT to 15-day post-LT samples in patients with advanced fibrosis at 1-year post-LT, suggesting that a VL increase on day 15 may be a predictor of fast liver fibrosis progression. HCV kinetics after LT differ between patients and are not fibrosis-dependent. Higher VL at day 15 post-LT versus pre-LT samples may predict fast liver fibrosis progression., This study was supported by grants from Instituto de Salud Carlos III cofinanced by the European Regional Development Fund (ERDF) with grant numbers PI19/00533, PI19/00301, Clinical Trial Gov. Identifier: NCT01707849, and from Centro para el Desarrollo Tecnológico Industrial-CDTI of the Spanish Ministry of Economics and Competitiveness (MINECO) grant number, IDI-20200297. C.P. is supported by the Miguel Servet program of Instituto de Salud Carlos III, grant CP14/00121, cofinanced by the ERDF. Astellas Pharma Inc and Novartis Pharma also provided funding for the study, but these companies had had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Deep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants

  • Garcia-Cehic, Damir
  • Campos, Carolina
  • Ibañez Lligoña, Marta
  • Colomer-Castell, Sergi
  • Gregori Font, Josep
  • Piñana, María
  • González-Sánchez, Alejandra
  • Rando Segura, Ariadna
  • Esperalba, Juliana
  • Saubi, Narcis
  • Cortese, Maria Francesca
  • Tabernero, David
  • Ferrer Costa, Roser
  • Esteban Mur, Juan Ignacio
  • Pumarola Suñe, Tomàs
  • QUER, JOSEP
  • Antón Pagarolas, Andrés
  • Andrés Vergés, Cristina
Omicron; Deep‐sequencing; Dual evolution, Òmicron; Seqüenciació profunda; Evolució dual, Ómicron; Secuenciación profunda; Evolución dual, SARS-CoV-2 has evolved from early variants dominating the first (B.1.5, B.1.1) and second (B.1.177) pandemic waves, which exhibited a higher frequency of minority mutants with deletions leading to Defective Viral Genomes (DVGs) in the spike region near the S1/S2 cleavage site than the Alpha, Beta, and Delta variants. The emergence of Omicron has significantly altered the dominant variant profile, with Omicron subvariants now representing 100% of circulating viruses. To monitor the evolution and adaptation of Omicron in the human population, a deep-sequencing study was performed in RNA samples of BA.1, BA.1.1, BA.2, BA.5, BQ.1.1, XBB.1.5 and BA.2.86 Omicron subvariants. The findings reveal two occurrences of similar evolutionary patterns within SARS-CoV-2 characterized by a shift from a significant to a very low production of DVGs. This event suggests that DVGs might play a role in the virus's spread and adaptation for persistence in infected humans., This study was supported by the Centro para el Desarrollo Tecnológico Industrial (CDTI) of the Spanish Ministry of Economy and Business, grant number IDI-20200297; Grant PID2021-126447OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by the ERDF A way of making Europe; Fondo de Investigación Sanitaria, Spanish Ministry of Economy and Competitiveness (grants FIS PI19/00301, PI19/00533, PI22/00258, PI22/00023, and PI23/01065); CIBER—Consorcio Centro de Investigación Biomédica en Red—(CIBERINFEC, ISCIII—CIBER of Infectious Diseases & CIBEREHD, ISCIII—CIBER of Hepatic and Digestive Diseases), Instituto de Salud Carlos III, Ministry of Science and Innovation and the European Union—NextGenerationEU. Research contributions of Wageningen Bioveterinary Research are funded from the ERRAZE (Early Response and Rapid Action Zoonotic Emergencies Program). C.C. received a predoctoral fellowship from the Vall d'Hebron Institute of Research (VHIR). M.I.-L. was supported by a fellowship from the “La Caixa” Foundation (ID 100010434), with code “LCF/BQ/DR23/12000020”. S.C-C. received support from the Spanish Ministry of Education grant FPU21/04150.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Deep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants

  • Campos, Carolina
  • Ibañez-Lligoña, Marta
  • Colomer‑Castell, Sergi
  • Gregori, Josep
  • Garcia‑Cehic, Damir
  • Andrés, Cristina
  • Piñana, Maria
  • González‑Sánchez, Alejandra
  • Rando‑Segura, Ariadna
  • Esperalba, Juliana
  • Saubí, Narcis
  • Cortese, Maria Francesca
  • Tabernero, David
  • Rodriguez-Frias, Francisco
  • Ferrer, Roser
  • Esteban, Juan Ignacio
  • Kakze-van der Honing, Renate W.
  • Kampfraath, Andries A.
  • Vergara-Alert, Júlia
  • Segalés, Joaquim
  • van der Poel, Wim H. M.
  • Pumarola, Tomàs
  • Antón, Andrés
  • Quer, Josep
SARS‐CoV‐2 has evolved from early variants dominating the first (B.1.5, B.1.1) and second (B.1.177) pandemic waves, which exhibited a higher frequency of minority mutants with deletions leading to Defective Viral Genomes (DVGs) in the spike region near the S1/S2 cleavage site than the Alpha, Beta, and Delta variants. The emergence of Omicron has significantly altered the dominant variant profile, with Omicron subvariants now representing 100% of circulating viruses. To monitor the evolution and adaptation of Omicron in the human population, a deep‐sequencing study was performed in RNA samples of BA.1, BA.1.1, BA.2, BA.5, BQ.1.1, XBB.1.5 and BA.2.86 Omicron subvariants. The findings reveal two occurrences of similar evolutionary patterns within SARS‐CoV‐2 characterized by a shift from a significant to a very low production of DVGs. This event suggests that DVGs might play a role in the virus's spread and adaptation for persistence in infected humans., This study was supported by Spanish Ministry of Education, Centro para el Desarrollo Tecnológico Industrial (CDTI), Fondo de Investigación Sanitaria, Spanish Ministry of Economy and Competitiveness, Fundació Institut de Recerca Hospital Universitari Vall d'Hebron, 'la Caixa' Foundation, Consorcio Centro de Investigación Biomédica en Red (CIBER), and Early Response and Rapid Action Zoonotic Emergencies Program (ERRAZE)., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prevalence of Hepatitis C Virus Infection, Genotypes and Subtypes in Migrants from Pakistan in Barcelona, Spain

  • Dopico, Eva|||0000-0002-5306-3035
  • Rodríguez Frías, Francisco|||0000-0002-9128-7013
  • Ubillos, Itziar|||0000-0002-0993-0058
  • Rando-Segura, Ariadna|||0000-0003-4555-7286
  • Garcia-Cehic, D.|||0000-0002-0009-038X
  • Gregori i Font, Josep|||0000-0002-4253-8015
  • Rando-Matos, Yolanda|||0000-0002-4274-5006
  • Solsona, Luis
  • Niubó, Jordi|||0000-0001-9511-0138
  • Esteban Mur, Juan Ignacio|||0000-0001-5085-917X
  • Costa, Josep|||0000-0001-7978-0748
  • Martínez, Miguel J.|||0000-0002-0682-1075
  • Quer, Josep|||0000-0003-0014-084X
Hepatitis C virus (HCV) is a major cause of chronic liver infection with 71 million people infected worldwide. Pakistan has the second highest prevalence of HCV infection and more than half (52%) of Pakistani living in Spain reside in Barcelona. The aim of this study was to analyse the seroprevalence and viraemic rate and determine the genotypes and subtypes of HCV among Pakistanis living in the southern metropolitan area of Barcelona. We included all Pakistani patients seeking primary healthcare in the southern metropolitan area of Barcelona from August 2011 to July 2014. Serum samples were screened for HCV antibodies. HCV viral load was determined by reverse transcription polymerase chain reaction and genotypes and subtypes were performed using Versant HCV Genotype and/or deep-sequencing. Screening for hepatitis B virus (HBV) was also carried out. Among 5877 Pakistani patients, 565 (9.61%) were screened for anti-HCV antibodies, with 68 (12.04%) being positive. The viral load was determined in 65, with 31 presenting active infection and the viraemic rate was 47.69% (95% confidence interval 36.02-59.62). HCV genotyping and subtyping were performed in 24 individuals. Most infections corresponded to HCV genotype 3 (91.67%), and high resolution HCV subtyping was performed in 18 samples, 16 of which presented subtype 3a. One subject presented HBV coinfection with undetectable HBV DNA. During the study period, we identified a possible case of HCV vertical transmission followed by spontaneous viraemia clearance in a chronically infected mother with a C/T IL28B genetic polymorphism. These results suggest that general HCV screening protocols in patients from high prevalence countries, such as Pakistan, would be helpful to identify and treat active HCV infections. This could avoid further transmission and contribute to building targeted health policies for micro-elimination of HCV infection in specific communities.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients

  • Llorens-Revull, Meritxell|||0000-0002-8671-8907
  • Gregori i Font, Josep|||0000-0002-4253-8015
  • Dopazo, Cristina|||0000-0001-6274-5911
  • Rodríguez Frías, Francisco|||0000-0002-9128-7013
  • Garcia-Cehic, D.|||0000-0002-0009-038X
  • Soria Benito, María Eugenia|||0000-0002-4719-3351
  • Chen, Qian
  • Rando-Segura, Ariadna|||0000-0003-4555-7286
  • Perales Viejo, Celia|||0000-0003-1618-1937
  • Esteban Mur, Juan Ignacio|||0000-0001-5085-917X
  • Quer, Josep|||0000-0003-0014-084X
  • Bilbao, Itxarone|||0000-0002-7389-395X
Cirrhosis derived from chronic hepatitis C virus (HCV) infection is still a common indication for liver transplantation (LT). Reinfection of the engrafted liver is universal in patients with detectable viral RNA at the time of transplant and causes fast progression of cirrhosis (within 5 years) in around one-third of these patients. To prevent damage to the liver graft, effective direct-acting antiviral (DAA) therapy is required as soon as possible. However, because of post-LT clinical instability, it is difficult to determine the optimal time to start DAAs with a low risk of complications. Evaluate changes in quasispecies complexity following LT and seek a predictive index of fast liver damage progression to determine the timing of DAA initiation. HCV genomes isolated from pre-LT and 15-day post-LT serum samples of ten patients, who underwent orthotopic LT, were quantified and sequenced using a next-generation sequencing platform. Sequence alignments, phylogenetic trees, quasispecies complexity measures, biostatistics analyses, adjusted R2 values, and analysis of variance (ANOVA) were carried out. Three different patterns of reinfection were observed (viral bottlenecking, conserved pre-LT population, and mixed populations), suggesting that bottlenecking or homogenization of the viral population is not a generalized effect after liver graft reinfection. None of the quasispecies complexity measures predicted the future degree of liver damage. Higher and more uniform viral load (VL) values were observed in all pre-LT samples, but values were more dispersed in post-LT samples. However, VL increased significantly from the pre-LT to 15-day post-LT samples in patients with advanced fibrosis at 1-year post-LT, suggesting that a VL increase on day 15 may be a predictor of fast liver fibrosis progression. HCV kinetics after LT differ between patients and are not fibrosis-dependent. Higher VL at day 15 post-LT versus pre-LT samples may predict fast liver fibrosis progression.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients

  • Llorens Revull, Meritxell
  • Dopazo Taboada, Cristina
  • Rodríguez Frias, Francisco
  • Garcia Cehic, Damir
  • Soria Benito, Maria Eugenia
  • Chen, Qian
  • Perales Viejo, Celia Belen
  • Quer Sivila, Josep
  • Bilbao Aguirre, Itxarone Izaskun
  • Rando Segura, Ariadna
  • Gregori Font, Josep
  • Esteban Mur, Juan Ignacio
Fibrosis; Hepatitis C virus; Viral load, Fibrosis; Virus de la hepatitis C; Carga viral, Fibrosi; Virus de l'hepatitis C; Càrrega viral, Cirrhosis derived from chronic hepatitis C virus (HCV) infection is still a common indication for liver transplantation (LT). Reinfection of the engrafted liver is universal in patients with detectable viral RNA at the time of transplant and causes fast progression of cirrhosis (within 5 years) in around one-third of these patients. To prevent damage to the liver graft, effective direct-acting antiviral (DAA) therapy is required as soon as possible. However, because of post-LT clinical instability, it is difficult to determine the optimal time to start DAAs with a low risk of complications. Evaluate changes in quasispecies complexity following LT and seek a predictive index of fast liver damage progression to determine the timing of DAA initiation. HCV genomes isolated from pre-LT and 15-day post-LT serum samples of ten patients, who underwent orthotopic LT, were quantified and sequenced using a next-generation sequencing platform. Sequence alignments, phylogenetic trees, quasispecies complexity measures, biostatistics analyses, adjusted R2 values, and analysis of variance (ANOVA) were carried out. Three different patterns of reinfection were observed (viral bottlenecking, conserved pre-LT population, and mixed populations), suggesting that bottlenecking or homogenization of the viral population is not a generalized effect after liver graft reinfection. None of the quasispecies complexity measures predicted the future degree of liver damage. Higher and more uniform viral load (VL) values were observed in all pre-LT samples, but values were more dispersed in post-LT samples. However, VL increased significantly from the pre-LT to 15-day post-LT samples in patients with advanced fibrosis at 1-year post-LT, suggesting that a VL increase on day 15 may be a predictor of fast liver fibrosis progression. HCV kinetics after LT differ between patients and are not fibrosis-dependent. Higher VL at day 15 post-LT versus pre-LT samples may predict fast liver fibrosis progression., This study was supported by grants from Instituto de Salud Carlos III cofinanced by the European Regional Development Fund (ERDF) with grant numbers PI19/00533, PI19/00301, Clinical Trial Gov. Identifier: NCT01707849, and from Centro para el Desarrollo Tecnológico Industrial-CDTI of the Spanish Ministry of Economics and Competitiveness (MINECO) grant number, IDI-20200297. C.P. is supported by the Miguel Servet program of Instituto de Salud Carlos III, grant CP14/00121, cofinanced by the ERDF. Astellas Pharma Inc and Novartis Pharma also provided funding for the study, but these companies had had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Deep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants

  • Garcia-Cehic, Damir
  • Campos, Carolina
  • Ibañez Lligoña, Marta
  • Colomer-Castell, Sergi
  • Gregori Font, Josep
  • Piñana, María
  • González-Sánchez, Alejandra
  • Rando Segura, Ariadna
  • Esperalba, Juliana
  • Saubi, Narcis
  • Cortese, Maria Francesca
  • Tabernero, David
  • Ferrer Costa, Roser
  • Esteban Mur, Juan Ignacio
  • Pumarola Suñe, Tomàs
  • QUER, JOSEP
  • Antón Pagarolas, Andrés
  • Andrés Vergés, Cristina
Omicron; Deep‐sequencing; Dual evolution, Òmicron; Seqüenciació profunda; Evolució dual, Ómicron; Secuenciación profunda; Evolución dual, SARS-CoV-2 has evolved from early variants dominating the first (B.1.5, B.1.1) and second (B.1.177) pandemic waves, which exhibited a higher frequency of minority mutants with deletions leading to Defective Viral Genomes (DVGs) in the spike region near the S1/S2 cleavage site than the Alpha, Beta, and Delta variants. The emergence of Omicron has significantly altered the dominant variant profile, with Omicron subvariants now representing 100% of circulating viruses. To monitor the evolution and adaptation of Omicron in the human population, a deep-sequencing study was performed in RNA samples of BA.1, BA.1.1, BA.2, BA.5, BQ.1.1, XBB.1.5 and BA.2.86 Omicron subvariants. The findings reveal two occurrences of similar evolutionary patterns within SARS-CoV-2 characterized by a shift from a significant to a very low production of DVGs. This event suggests that DVGs might play a role in the virus's spread and adaptation for persistence in infected humans., This study was supported by the Centro para el Desarrollo Tecnológico Industrial (CDTI) of the Spanish Ministry of Economy and Business, grant number IDI-20200297; Grant PID2021-126447OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by the ERDF A way of making Europe; Fondo de Investigación Sanitaria, Spanish Ministry of Economy and Competitiveness (grants FIS PI19/00301, PI19/00533, PI22/00258, PI22/00023, and PI23/01065); CIBER—Consorcio Centro de Investigación Biomédica en Red—(CIBERINFEC, ISCIII—CIBER of Infectious Diseases & CIBEREHD, ISCIII—CIBER of Hepatic and Digestive Diseases), Instituto de Salud Carlos III, Ministry of Science and Innovation and the European Union—NextGenerationEU. Research contributions of Wageningen Bioveterinary Research are funded from the ERRAZE (Early Response and Rapid Action Zoonotic Emergencies Program). C.C. received a predoctoral fellowship from the Vall d'Hebron Institute of Research (VHIR). M.I.-L. was supported by a fellowship from the “La Caixa” Foundation (ID 100010434), with code “LCF/BQ/DR23/12000020”. S.C-C. received support from the Spanish Ministry of Education grant FPU21/04150.